𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study

✍ Scribed by Karen Au; Maureen D. Mayes; Paul Maranian; Philip J. Clements; Dinesh Khanna; Virginia D. Steen; Donald Tashkin; Michael D. Roth; Robert Elashoff; Daniel E. Furst

Publisher
Wiley (John Wiley & Sons)
Year
2010
Tongue
English
Weight
121 KB
Volume
62
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

D-penicillamine treatment of lung involv
D-penicillamine treatment of lung involvement in patients with systemic sclerosis (scleroderma)
✍ Thomas A. Medsger Jr. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 194 KB πŸ‘ 1 views

D-penicillamine has been used to treat systemic sclerosis (scleroderma) for nearly two decades. Improvement in cutaneous fibrosis in patients treated with this drug has been documented in a number of uncontrolled studies (1). The effect of D-penicillamine on established visceral involvement due to s

Impact of oral cyclophosphamide on healt
Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease: Results from the scleroderma lung study
✍ Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 1 views

## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC